v3.26.3
Net Loss Per Share Attributable to Common Stockholders
9 Months Ended
Sep. 30, 2026
Net Loss Per Share Attributable to Common Stockholders [Abstract]  
Net Loss Per Share Attributable to Common Stockholders

15. Net Loss Per Share Attributable to Common Stockholders

 

Basic net loss per share attributable to the Company’s common stockholders is computed by dividing the net loss attributable to the Company’s common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is the same as basic net loss per share for all periods presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss position in each period presented.

 

In connection with the Merger, all outstanding shares of Legacy Ionetix common stock and redeemable convertible preferred stock were converted into shares of the Company’s common stock based on the Conversion Ratio. In addition, all outstanding Legacy Ionetix options and warrants were assumed by the Company and converted into options and warrants, respectively, to purchase shares of the Company’s common stock, with the number of underlying shares and exercise price adjusted based on the Conversion Ratio. The weighted-average shares outstanding and net loss per share for periods prior to the Merger have been retroactively adjusted to reflect the Conversion Ratio.

 

The following table presents the calculation of basic and diluted net loss per share for the three and nine months ended September 30, 2026 and 2025:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
Net loss attributable to common stockholders   $ (4,937 )   $ (6,692 )   $ (27,177 )   $ (17,073 )
Weighted-average shares outstanding, basic and diluted     109,999,870       12,786,148       75,945,785       12,702,432  
Net loss per share, basic and diluted   $ (0.04 )   $ (0.52 )   $ (0.36 )   $ (1.34 )

 

The following outstanding potential shares of common stock were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2026     2025     2026     2025  
Redeemable convertible preferred stock     —       50,500,239       —       50,500,239  
Outstanding stock options     6,742,311       7,518,402       6,742,311       7,518,402  
Preferred stock warrants     —       55,154       —       55,154  
Common stock warrants     4,581,027       3,648,890       4,581,027       3,648,890  
Convertible notes     —       3,946,497       —       3,946,497  
SAFE liabilities     —       14,160,720       —       14,160,720  
Total     11,323,338       79,829,902       11,323,338       79,829,902